Research Chemist II @ Miravant Pharmaceuticals, Inc
Dipanjan Sengupta's Education
UC Santa Barbara
Postdoctoral Research (Bio-Organic Chemistry)
1994 - 1996
University at Albany, SUNY
Postdoctoral Research (Organic Chemistry)
1991 - 1994
Arizona State University
Postdoctoral Research (Organic Chemistry)
1987 - 1991
Indian Association for the Cultivation of Science, Calcutta
Ph.D. (Organic Chemistry)
1982 - 1987
Dipanjan Sengupta's Skills
Medicinal Chemistry
Drug Discovery
Research And Development R&D
CRO Management
Process Research
Organic Chemistry
Good Laboratory Practice Glp
Drug Development
Technology Transfer
GMP
Dipanjan Sengupta's Summary
Dipanjan Sengupta, based in San Diego, CA, US, is currently a Director, API Process R and D, CMC at Kura Oncology, Inc., bringing experience from previous roles at Kura Oncology, Inc., Mirati Therapeutics, STA Pharmaceuticals US LLC (A WuXi AppTec Company) and Ardea Biosciences (a member of the AstraZeneca Group). Dipanjan Sengupta holds a 1994 - 1996 Postdoctoral Research in Bio-Organic Chemistry @ UC Santa Barbara. With a robust skill set that includes Medicinal Chemistry, Drug Discovery, Research And Development R&D, CRO Management, Process Research and more, Dipanjan Sengupta contributes valuable insights to the industry. Dipanjan Sengupta has 3 emails on RocketReach.